Evolution of the SARS‐CoV‐2 omicron variants BA. 1 to BA. 5: implications for immune escape and transmission

LB Shrestha, C Foster, W Rawlinson… - Reviews in Medical …, 2022 - Wiley Online Library
The first dominant SARS‐CoV‐2 Omicron variant BA. 1 harbours 35 mutations in its Spike
protein from the original SARS‐CoV‐2 variant that emerged late 2019. Soon after its …

A detailed overview of SARS-CoV-2 omicron: its sub-variants, mutations and pathophysiology, clinical characteristics, immunological landscape, immune escape, and …

S Chatterjee, M Bhattacharya, S Nag, K Dhama… - Viruses, 2023 - mdpi.com
The COVID-19 pandemic has created significant concern for everyone. Recent data from
many worldwide reports suggest that most infections are caused by the Omicron variant and …

VV116 versus nirmatrelvir–ritonavir for oral treatment of Covid-19

Z Cao, W Gao, H Bao, H Feng, S Mei… - … England Journal of …, 2023 - Mass Medical Soc
Background Nirmatrelvir–ritonavir has been authorized for emergency use by many
countries for the treatment of coronavirus disease 2019 (Covid-19). However, the supply …

[HTML][HTML] Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients

M Taquet, R Sillett, L Zhu, J Mendel… - The Lancet …, 2022 - thelancet.com
Background COVID-19 is associated with increased risks of neurological and psychiatric
sequelae in the weeks and months thereafter. How long these risks remain, whether they …

Variant-specific symptoms of COVID-19 in a study of 1,542,510 adults in England

M Whitaker, J Elliott, B Bodinier, W Barclay… - Nature …, 2022 - nature.com
Infection with SARS-CoV-2 virus is associated with a wide range of symptoms. The REal-
time Assessment of Community Transmission− 1 (REACT-1) study monitored the spread …

[HTML][HTML] Olfactory dysfunction in COVID-19: new insights into the underlying mechanisms

R Butowt, K Bilinska, CS von Bartheld - Trends in Neurosciences, 2023 - cell.com
The mechanisms of olfactory dysfunction in COVID-19 are still unclear. In this review, we
examine potential mechanisms that may explain why the sense of smell is lost or altered …

Omicron-associated changes in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) symptoms in the United Kingdom

KD Vihta, KB Pouwels, TEA Peto… - Clinical Infectious …, 2023 - academic.oup.com
Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta
variant has been replaced by the highly transmissible Omicron BA. 1 variant, and …

The neurobiology of SARS-CoV-2 infection

J Meinhardt, S Streit, C Dittmayer, RV Manitius… - Nature Reviews …, 2024 - nature.com
Worldwide, over 694 million people have been infected with SARS-CoV-2, with an estimated
55–60% of those infected develo** COVID-19. Since the beginning of the pandemic in …

Current and emerging knowledge in COVID-19

YJ Jeong, YM Wi, H Park, JE Lee, SH Kim, KS Lee - Radiology, 2023 - pubs.rsna.org
COVID-19 has emerged as a pandemic leading to a global public health crisis of
unprecedented morbidity. A comprehensive insight into the imaging of COVID-19 has …

Severity and outcomes of Omicron variant of SARS-CoV-2 compared to Delta variant and severity of Omicron sublineages: a systematic review and metanalysis

P Relan, NV Motaze, K Kothari, L Askie… - BMJ Global …, 2023 - gh.bmj.com
Objectives To compare severity and clinical outcomes from Omicron as compared with the
Delta variant and to compare outcomes between Omicron sublineages. Methods We …